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Background: Insulin-like growth factor-1 (IGF-1) is produced in various tissues to stimulate protein synthesis under
different conditions. It is however, difficult to distinguish effects by locally produced IGF-1 compared to
liver-derived IGF-1 appearing in the circulation. In the present study the role of liver-derived endocrine IGF-I for
activation of skeletal muscle protein synthesis following feeding was evaluated.
Results: Transgenic female mice with selective knockout of the IGF-I gene in hepatocytes were freely fed, starved
overnight and subsequently refed for 3 hours and compared to wild types (wt). Liver IGF-I knockout mice had 70%
reduced plasma IGF-I. Starvation decreased and refeeding increased muscle protein synthesis (p < 0.01), similarly in
both IGF-I knockouts and wt mice. Phosphorylation of p70s6k and mTOR increased and 4EBP1 bound to eIF4E
decreased in both IGF-I knockouts and wt mice after refeeding (p < 0.05). Muscle transcripts of IGF-I decreased and
IGF-I receptor increased (p < 0.01) in wild types during starvation but similar alterations did not reach significance in
knockouts (p>0.05). mTOR mRNA increased in knockouts only during starvation. Plasma glucose decreased during
starvation in all groups in parallel to insulin, while plasma IGF-I and GH did not change significantly among the
groups during starvation-refeeding. Plasma amino acids declined and increased during starvation-refeeding in wild
type mice (p < 0.05), but less so in IGF-I (−/−) knockouts (p < 0.08).
Conclusion: This study demonstrates that re-synthesis of muscle proteins following starvation is not critically
dependent on endocrine liver-derived IGF-I.
Keywords: IGF-I, Muscle protein synthesis, Cell signaling, Amino acidBackground
Protein synthesis is rapidly increased in skeletal muscles
after oral feeding due to intracellular signaling for activa-
tion of initiation or protein translation [1], which is quan-
titatively the most important alteration in the control of
short term protein balance in skeletal muscles [2,3]. Meal
feeding is a complex stimuli where nutrients are provided
and appear simultaneously with changes in circulating
levels of hormones and substrates as well as hormone
binding proteins. Our earlier studies have suggested that
amino acids are important substrate factor(s) behind post-
feeding activation of muscle protein synthesis, whereas in-
sulin seems rather permissive [4,5]. On the other hand, it* Correspondence: britt-marie.iresjo@surgery.gu.se
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reproduction in any medium, provided the orcan be expected that insulin-like growth factor I (IGF-I)
should be involved since provision of anti IGF-I antibodies
before meal feeding attenuated a subsequent rise in pro-
tein synthesis [5], besides its well-recognized effects on
muscle cell proliferation and regeneration [6-8]. Further-
more, blood levels and muscle expression of IGF-I are sig-
nificantly changed during starvation and feeding [5,9]. The
role of endocrine liver-derived and locally tissue produced
IGF-I to promote protein synthesis in response to feeding
is however unclear, in part due to complex conditions with
different IGF-binding proteins, which may also have inde-
pendent control functions of net protein metabolism at
tissue levels [10-12]. This complexity makes it uncertain
to define roles of locally produced versus endocrine liver-
derived IGF-I for activation of protein translation and syn-
thesis in skeletal muscle tissue following feeding [13,14].
The aim of the present study was therefore to evaluate thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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translation initiation of muscle proteins at refeeding in a
transgenic mouse model with selectively and conditionally
deleted liver IGF-I [15]. This deletion caused levels of cir-
culating IGF-I to be reduced by 70% compared to wild
type controls in combination with normal muscle expres-
sion of IGF-I [15].
Methods
Animals
Transgenic female mice (C57BL/6) with inducible inacti-
vation of the Insulin-like growth factor-1 gene constructed
with the Cre/LoxP system were used. Animals were bred
as described earlier [15]. Recombination was induced by
polyinosinic-polycytidylic acid (PiPc) treatment at 10–12
weeks of age in mice homozygous for loxP and heterozy-
gous for Mx-Cre, [15,16]. These mice are referred to as
liver IGF-I knockouts, Li-IGF-I (−/−). PiPc treated siblings,
homozygous for LoxP but lacking Mx-Cre, were used as
controls and referred to as wild type animals, WT (+/+).
Adult weight stable Li-IGF-I (−/−) mice housed with 5 ani-
mals per cage, matured normally with normal body com-
position as compared to our previous experiments on
partially IGF-I knockouts (+/−) [9]. Body weight was 22.2
±0.1 g in knockouts and 23.8±0.10 g in wild types at the
start of experiments, in 5 months old mice; which is be-
fore any alterations in body composition in knockouts
[17]. Male animals were not used since they must be
housed individually in this kind of experiment; a condition
which is associated with stress reactions and adaptations.
However, females are subjected to hormone alterations
during the estrous cycle, which could theoretically induce
alterations in muscle protein metabolism. However, com-
parisons of rates of muscle protein synthesis between
phases of the menstrual cycle are limited. Miller et.al.
found no effect of the menstrual cycle phases in human fe-
males [18], while Toth et.al. reported minor changes in
the gastrocnemius fractional synthesis rate related to es-
tradiol or progesterone replacement therapy in ovariecto-
mized rats [19]. Therefore, all our experiments were
carried out with mice randomly divided across cages
housed simultaneously and close together, in order to pro-
mote estrous synchronization within and across cages.
Liver IGF-I knockouts and wild type mice were used
across the groups; freely fed, starved and refed animals.
Freely fed animals had continuous access to water ad lib.
and standard rodent chow (2016 Global Tekland®,
Netherlands). Starved mice had no access to food over-
night for 12 hours before experiments, while refed animals
were similarly starved overnight for 12 hours and had then
free access to food during 3 hours before termination
according to previous findings [4,9,20]. Animals were
killed by cervical dislocation and blood samples were
drawn by cardiac puncture. Mixed hind limb muscles fromboth legs were excised. Muscles from one leg were used for
measurements of fractional protein synthesis and protein
measurements. Muscle tissue from the other leg was used
for RNA extraction and RNA expression analyses.
All animal procedures were performed in accordance
to Swedish law (Animal welfare act, 1988:538) and na-
tional guidelines for care and use of research animals
(DFS 2004:4) and approved by the regional ethics com-
mittee for animal research in Gothenburg (450–2008).
RNA expression
Hind limb mixed muscle tissue were snap-frozen in li-
quid nitrogen and kept in −70°C until analysis. RNA was
extracted using RNeasy fibrous tissue kit (Qiagen) with
DNAse step included. Total RNA concentrations were
measured by spectrophotometer (Nanodrop ND-100)
and RNA quality was checked by calculating the 18S/
28S ratio using an Agilent 2100 bioanalyser. One μg of
total RNA was reverse transcribed using oligo d(T)-pri-
mer according to kit instructions (Advantage RT for
PCR kit,) for cDNA synthesis. Positive and negative con-
trols were included in each run of cDNA synthesis.
Realtime PCR was performed with a LightCycler 1.5 in-
strument (Roche) using the LightCycler FastStart DNA
MasterPLUSSYBR Green 1 kit. For analysis of Igf-1, 2 μl
cDNA and 10 pmol of forward (GCT CTT CAG TTC
GTG TGT GGA C) and reverse (CAT CTC CAG TCT
CCT CAG ATC) primers were used to each reaction of
20 μl. PCR were performed with the following settings;
denaturation 95°C for 10 sec., annealing 64°C, 4 sec. and
extension 72°C, 6 sec. For analysis of Igf-1r (Quantitect
Primer assay Nr QT00155351, Qiagen), 2 μl cDNA and
2 μl of premixed Quantitect primers were used for each
reaction of 20 μl. PCR were performed with the follow-
ing settings; denaturation 95°C for 10 sec., annealing
60°C, 6 sec. and extension 72°C, 5 sec. For analysis of Akt
(QT00114401), mTOR (QT01532916) and PI3-kinase
(QT00149709), 2 μl cDNA and 2 μl of premixed Quantitect
primers were used for each reaction of 20 μl. Real time
PCR were performed using QuantiFast™SYBR Green PCR
kit (Qiagen). Quantitative results were produced by the
relative standard curve method. All samples were analyzed
in duplicates and negative controls were included in each
run. All results are related to the expression of Gapdh
as housekeeping gene according to separate evaluations
among 12 gene alternatives, where Gapdh showed minimal
alterations in response to starvation/refeeding with 8% vari-
ation among all the groups at extreme conditions as starva-
tion/refeeding (0.15<p>0.80).
Protein synthesis
Fractional liver and skeletal muscle protein synthesis were
measured by the flooding dose technique as described
[21,22]. A single dose injection of L-[U-14C] phenylalanine
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minutes before killing. Liver tissue and mixed hind limb
muscles were rapidly excised and frozen in liquid nitrogen
until analysis. Blood samples were heparinized and imme-
diately centrifuged at +4°C and plasma was frozen until
analysis. Fractional synthesis rate (% × hr-1) was calculated
as described [9].Western blotting
Mixed hind limb muscles were rapidly excised and
frozen in liquid nitrogen until next day when biopsies were
thawed and homogenized in seven volumes of ice-cold buf-
fer A (20 mM Hepes, pH 7.4, 100 mM KCl, 0.2 mM EDTA,
2 mM EGTA, 1 mM DTT, 50 mM NaF, 50 mM
β−glycerophosphate, 0.1 mM AEBSF, 1 mM bensamidine,
0.5 mM sodium vanadate). The homogenate was
centrifuged at 10 000 × g for 10 min at 4°C. Aliquots of
the supernatant were used for western blot analysis of phos-
phorylation state of 4EBP1 and p70s6 kinase or immu-
noprecipitated for analysis of 4EBP1 · eIF4E complexes as
previously described [23]. Anti-eIF4E antibodies used
were a kind gift from Dr Scot Kimball, Pennsylvania State
University, USA. All blot membranes were exposed
to Hyperfilm ECL (Amersham Biosciences, UK) and
quantification was carried out with Quantity One software
(Bio-Rad Laboratories AB, Sundbyberg, Sweden). For quan-
tification of 4EBP1 · eIF4E complex the total optical density
was measured and the results were corrected for eIF4E con-
tent. Optical density is expressed in arbitrary units. The
phosphorylation state of 4EBP1 is expressed as percentage
of the most phosphorylated γ-form compared to the total
and calculated as optical density of the γ-band/optical dens-
ity of all bands [(α+β+γ)*100]. Phosphorylation state of
p70s6 kinase was measured by gel mobility shift and is
expressed as percentage of the least phosphorylated α form
compared to the total and calculated as optical density of
the α-band/optical density of all bands [(α+β+γ)*100]. For
measurement of mTOR and phosphorylated mTOR2448, al-
iquots of the homogenate supernatant were mixed with
equal volumes of 2x SDS electrophoresis sample buffer and
separated in a 3-8% NuPage Tris-acetate mini gel
(Invitrogen). Proteins were transferred to PVDF mem-
branes, which were incubated over night at +4°C with a
rabbit anti mouse mTOR2448 antibody (#2971, Cell Signal-
ing Technology) after blocking in 10% nonfat dry milk in
Tris-buffered Saline-Tween 20. The blots were then
washed, incubated with secondary antibodies and devel-
oped using an ECL Western Blotting Kit according to the
manufacturers description (Amersham Biosciences, UK)
and exposed against Hyperfilm ECL (Amersham Biosci-
ences, UK). After detection of signals, antibodies were re-
moved by 45 minutes incubation at +50°C in stripping
buffer (100 mM 2-mercaptoethanol, 2% sodium dodecylsulfat (SDS), 62.5 mM Tris–HCl pH 7.6) and membranes
were thereafter reprobed for measurement of total mTOR
by incubating membranes 75 min at room temperature
with a rabbit anti human mTOR antibody (sc-8319, Santa
Cruz biotechnology, Santa Cruz, USA) Quantification of
signals was carried out with GS-710 imaging densitometer
and Quantity One software (Bio-Rad Laboratories AB,
Sundbyberg, Sweden). Measured optical density was
expressed as arbitrary units. On each gel, 2 lanes were
loaded with MagicMark XP Western Protein Standards
(Invitrogen). The average optical density for the standard
band with most similar molecular size as the measured pro-
tein was used to normalize signal intensity between blots.Western ligand blotting
IGF-I ligand blotting was performed under conditions de-
scribed by Hosssenlopp et.al. [24]. Equal volumes from
each supernatant with similar amount of proteins of the
prepared muscle homogenates in one group were pooled
and mixed with an equal volume of Laemmli sample buf-
fer and heated to 95°C. 15 μl of the samples were sepa-
rated by electrophoresis on 12% Tris-Glycine gels using
non-reduced conditions and transferred to PVDF mem-
branes. Membranes were blocked and incubated overnight
with 125I-labelled IGF-I (PerkinElmer). After washing,
blots were exposed to Hyperfilm MP at −70°C. Films were
scanned and band intensity was measured (Quantity One
software, GS-710 densitometer, BioRad). The molecular
weight of IGFBPs was estimated from prestained
standards.Plasma concentrations
Plasma IGF-I was measured by an IGF-I binding protein
blocked RIA (Mediagnost). Glucose was measured with
the glucose oxidase method according to the manufac-
turers’ instructions (Roche). Plasma amino acids were ana-
lyzed by HPLC as described elsewhere [25,26], in order to
relate alterations in Igf-I/Igf-Ir transcript expression to
changes in plasma amino acids, which may be stimulators
of muscle protein synthesis [20,27]. Growth hormone
(GH) and insulin were measured with ELISA methods
(Linco research). Plasma IGFBPs were not measured since
IGFBPs were estimated in the muscle tissue compartment.Statistics
Results are presented as mean ± SEM based on 8 animals
in each group except for 7 mice in starved wild type and 9
in Li-IGF-I (−/−). Factorial ANOVA was used to test within
groups and among groups followed by Fisher PLSD test
for multiple comparisons. P<0.05 was considered statisti-
cally significant and p < 0.10 a trend to significance in two
tailed tests.
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Plasma concentrations
Plasma levels of IGF-I were reduced by 70% in liver IGF-I
knockout mice (Li-IGF-I (−/−)) compared to wild type mice
at all nutritional conditions (<0.001), while glucose and in-
sulin levels were comparable among Li-IGF-I (−/−) and
wild type mice. Overnight starvation caused a significant
decrease in plasma glucose compared to freely fed mice in
both knockout and wt mice (p<0.05) (Table 1). Growth
hormone did not change significantly within groups dur-
ing freely feeding, starvation and refeeding and it was not
significantly altered when comparing between groups.
Branched chain and essential amino acids were signifi-
cantly altered during starvation-refeeding in wild type
mice, but not in liver IGF-I knockouts. These alterations
were also reflected in concentrations of the sum of all
amino acids (Table 2).
Protein synthesis
The magnitude of basal fractional synthesis rate in liver
and muscle tissue was comparable in freely fed wild type
and liver IGF-I knockout mice. Refeeding increased simi-
larly liver (p < 0.10) and muscle protein synthesis (p < 0.01)
compared to starvation in both wild type and liver IGF-I
knockout animals (Figure 1A,B).
RNA transcripts in skeletal muscles
mRNA transcript levels were comparable in freely fed
wild type and knockout mice (Igf-I, Igf-Ireceptor, PI3-
kinase, Akt and mTOR). However, Igf-I transcripts de-
creased significantly in muscles from wild type mice
during starvation but with a different time course in
knockouts. Igf-Ir increased similarly during starvation
in both wild type and knockout mice and remained in-
creased during refeeding (Figure 2A-B). Significant
changes in transcript levels of PI3k and Akt were not
observed (PI3-kinase: WT, FF 1.40±0.15, ST 1.12±0.16,
RF 1.54±0.21; Li-IGF(−/−), FF 1.13±0.18, ST 1.62±0.17,
RF 1.50±0.26) (Akt: WT, FF 1.09±0.15, ST 1.14±0.08,Table 1 Plasma concentrations in study (starved, refed) and c
knockout mice
Freely fed Starved
Glucose (mmol/l) wt 10.4 ± 0.5 8.0 ± 0.6
IGF- 12.3 ± 1.2 8.1 ± 0.6
Insulin (μg/l) wt 0.58±0.09 0.35±0.05
IGF- 1.11±0.26 0.43±0.07
IGF-I (μg/l) wt 172 ± 13 138 ± 13
IGF- 58 ± 7 40 ± 7
GH (μg/l)a wt 2.0±0.8 5.1±2.1
IGF- 11.5±8.5 15±6.1
Mean±SEM.
A measured at 9 a.m.RF 1.41±0.16; Li-IGF(−/−), FF 1.12±0.13, ST 1.54±.24, RF
1.49±0.17). By contrast, mTOR expression was signifi-
cantly increased in starved knockout animals compared
to refed mice without any similar change in wild type
mice (Figure 2C). However, this increased transcript
level did not correspond to altered mTOR protein levels
among animal groups (not shown).
Translational and cell signaling proteins in skeletal
muscle tissue
The 4EBP1 · eIF4E complex, 4EBP1 phosphorylation state
(% γ of total), p70s6k phosphorylation (% α of total) and
mTOR posporylation (p-mTORser2448/mTORtotal) were
comparable among wild type and liver IGF-I knockout
mice. Starvation significantly increased muscle content of
4EBP1 · eIF4E complexes with corresponding normalization
in refed animals (Figure 3A). The 4EBP1 phosphorylation
state was significantly and similarly decreased in starved
mice compared to freely fed mice with significant increase
in refed wild type and liver IGF-I knockout mice
(Figure 3B). p70s6k and mTOR2448 was less phosphorylated
in starved wild type and liver IGF-I knockout mice with
complete reversal in both groups during refeeding
(Figure 3C,D,E). IGFBP content was similar among all
groups (Figure 4) indicating comparable extracellular con-
ditions of binding proteins among the groups.
Discussion
Anabolic effects by IGF-I are well recognized, particularly
such as stimulation of protein synthesis related to cell pro-
liferation, tissue growth and cell differentiation [6,28]. Parts
of these effects are probably mediated by muscle tissue
specific IGF-I isoforms such as the mechano growth factor
[29]. We have earlier assumed that circulating IGF-I is in-
volved in promotion of diurnal alterations of muscle pro-
tein synthesis in response to meal feeding [14]; where a
similar role may be assumed for insulin [5]. Our earlier
studies have, however, not confirmed an important and
primary role of insulin in physiologic resynthesis of skeletalontrol mice (freely fed) from wild type and liver IGF-I
Refed Within groups p< Among groups p<
11.3 ± 0.4 0.05
10.0 ± 0.8 0.05 ns
0.93±0.16 0.01
0.98±0.20 0.05 ns
159 ± 8 ns
46 ± 7 ns 0.01
12.6±7.3 ns
17.6±11.3 ns ns
Table 2 Plasma amino acids in freely fed, starved and refed mice as described in material and methods
Freely fed Starved Refed Within groups p<0.05 Among groups p<0.05
μmol/liter
Essential AA
Isoleucine wt 61 ± 6 56 ± 4 67 ± 9 ns
IGF- 59 ± 6 72 ± 7 50 ± 6 ns ns
Leucine wt 124 ± 17 84 ± 6 179 ± 29 0.05
IGF- 111 ± 12 114 ± 11 131 ± 20 ns ns
Valine wt 161 ± 16 120 ± 6 176 ± 20 ns
IGF- 152 ± 12 156 ± 13 143 ± 17 ns ns
BCAA wt 346 ± 38 260 ± 16 422 ± 58 0.05
IGF- 321 ± 28 342 ± 31 325 ± 43 ns ns
Lysine wt 258 ± 16 246 ± 16 277 ± 14 ns
IGF- 281 ± 21 282 ± 26 273 ± 21 ns ns
Methionine wt 55 ± 7 41 ± 5 97 ± 10 0.001
IGF- 48 ± 5 38 ± 3 77 ± 13 0.01 ns
Phenylalanine wt 287 ± 37 389 ± 107 386 ± 93 ns
IGF- 402 ± 86 277 ± 36 311 ± 72 ns ns
Threonine wt 147 ± 14 119 ± 10 207 ± 13 0.05
IGF- 125 ± 7 114 ± 8 162 ± 20 0.05 0.05
Tryptophan wt 34 ± 4 30 ± 3 42 ± 4 ns
IGF- 36 ± 3 35 ± 4 33 ± 3 ns ns
Essential AA wt 1127 ± 80 1086 ± 119 1433 ± 89 0.05
IGF- 1213 ± 112 1089 ± 70 1181 ± 91 ns ns
Non-essential AA
Alanine wt 337 ± 33 262 ± 37 547 ± 47 0.001
IGF- 283 ± 26 194 ± 13 459 ± 44 0.001 0,01
Arginine wt 77 ± 12 20 ± 7 43 ± 10 0.01
IGF- 56 ± 14 41 ± 9 30 ± 10 ns ns
Aspartic acid wt 37 ± 6 34 ± 3 25 ± 3 ns
IGF- 22 ± 2 40 ± 6 33 ± 4 ns ns
Asparagine wt 31 ± 2 27 ± 2 41 ± 2 0.01
IGF- 25 ± 2 25 ± 1 32 ± 3 ns 0.01
Citrulline wt 30 ± 3 20 ± 2 34 ± 2 0.01
IGF- 29 ± 2 20 ± 1 30 ± 3 0.01 ns
Glutamic acid wt 166 ± 18 152 ± 16 129 ± 15 ns
IGF- 166 ± 11 138 ± 13 158 ± 23 ns ns
Glutamine wt 538 ± 36 520 ± 30 578 ± 31 ns
IGF- 553 ± 27 516 ± 42 560 ± 35 ns ns
Glycine wt 174 ± 18 170 ± 17 178 ± 10 ns
IGF- 150 ± 9 140 ± 15 175 ± 24 ns ns
Histidine wt 53 ± 4 50 ± 3 70 ± 4 0.01
IGF- 57 ± 4 52 ± 4 64 ± 4 ns ns
Serine wt 108 ± 12 85 ± 5 136 ± 5 0.01
IGF- 93 ± 16 75 ± 5 118 ± 9 0.01 ns
Tyrosine wt 330 ± 23 395 ± 65 339 ± 82 ns
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Table 2 Plasma amino acids in freely fed, starved and refed mice as described in material and methods (Continued)
IGF- 323 ± 39 239 ± 40 285 ± 59 ns ns
Ornitine wt 88 ± 22 90 ± 12 109 ± 16 ns
IGF- 109 ± 16 83 ± 15 115 ± 10 ns ns
α-Aba wt 7 ± 1 8 ± 1 9 ± 1 ns
IGF- 6 ± 1 6 ± 1 8 ± 1 ns ns
Non-ess. AA wt 1977 ± 142 1835 ± 149 2237 ± 89 ns
IGF- 1872 ± 71 1570 ± 112 2065 ± 125 0.05 ns
Total AA wt 3103 ± 219 2921 ± 264 3669 ± 143 0.05
IGF- 3085 ± 171 2659 ± 180 3246 ± 205 0.08 ns
Mean±SEM.
wt = wild type mice.
IGF- = hepatic deficient IGF-I (−/−) mice.
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[4], as well as in human skeletal muscles, where insulin
only attenuated break down of non-myofibrillar proteins
[2]. Therefore, we assumed that endocrine IGF-I may have
a role in stimulation of diurnal variations of protein synthe-




































Figure 1 A,B Effects of starvation-refeeding on synthesis rate of prote
with the “flooding dose” technique ([14C]-Phe) as described. Animals were
period as described in Methods. Results are mean ± SEM for 7–9 animals pof substrates and amino acids across cell membranes [30].
A role of IGF-1 was also tempting, when we observed that
locally expressed IGF-I decreased in muscle tissue follow-
ing overnight starvation and increased in response to meal
feeding [5]. However, the complex situation, with protein





ins in mixed skeletal muscle and liver tissue. FSR% was measured
freely fed, starved for 12 hours or refed during 3 hours after starvation









































































Figure 2 A-C Effects of starvation-refeeding on Igf-I, Igf-Ir and mTOR mRNA content in skeletal muscle tissue. Analyzed by quantitative
PCR using SYBRgreen detection. Results are mean ± SEM for 7–9 animals per group. a-p<0.05 vs. freely fed animals. b-<0.05 vs. freely fed and
refed animals.
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IGF-I compartments, particularly when binding proteins
themselves may have independent regulatory functions
across muscle membranes [11,12]. Therefore, it seemed in-
teresting to apply investigations in liver IGF-I knockout
mice, where IGF-I in the circulation is low due to a lack in
production of IGF-I in the liver and spleen, in order to re-
examine the role of circulating level versus local tissueexpression of IGF-I/IGF-IR for alterations in skeletal
muscle protein synthesis during starvation-refeeding [5,9].
Earlier attempts to study nutritional effects by IGF-I
have not provided unanimous and conclusive results
[5,9,31]. We found that injection of anti IGF-I antibodies
before feeding of mice attenuated a subsequent rise in
protein synthesis by 25%, while ip. injections of IGF-I to
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Figure 3 A-E Effects of starvation-refeeding on total 4E-BP1 · eIF4E complex (A), 4E-BP1 · phosphorylation (B) p70s6kinase
phosphorylation (C) and mTOR phosphorylation in skeletal muscle tissue. Figure 3E is a representative blot, one of four, of each analysis.
Proteins were immunoprecipitated with a monoclonal anti-eIF4E antibody and thereafter analyzed by Western blot with an antibody against
4E-BP1 in analysis of 4E-BP1 · eIF4E complex. Results are mean ± SEM with 7–9 animals per group. a-p<0.01 vs. freely fed and refed mice. All blot
analyses were perfomed on the same protein extracts with the same amount of total protein applied among the groups (not shown).
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http://www.biomedcentral.com/1472-6793/13/7marginally [5], and studies on genetically altered mice
implied that fractional resynthesis of muscle protein was
not clear-cut related to circulating GH, blood IGF-I and
locally produced IGF-I mRNA [9]. Others have however
reported that a one hour iv. infusion of IGF-I to over-
night starved mice increased muscle protein synthesis to
levels comparable to fed mice [32]. Furthermore, re-
duced free plasma IGF-I by 50% of normal levels, by in-
fusion of IGF binding protein 1, decreased muscle
protein synthesis by 25% with decreased phosphorylation
of p70s6 kinase [33], while provision of IGF-I/IGFBP-3
complex improved sepsis induced muscle catabolism
[34]. However, plasma IGF-I did not diverge from basal
levels in humans who received a drink of essential amino
acids at a time when muscle protein synthesis was stim-
ulated by more than 100% [35]. Another study in
humans evaluated effects by IGF-I when infused directly
into arm muscle bed compared to systemically raised
IGF-I [36], where protein synthesis was only increased
subsequently to locally infused IGF-I. A study, based on
microdialysis, revealed that concentrations of free IGF-I
in muscle interstitial fluid were 20 fold higher than sim-
ultaneous plasma levels, supporting that circulating IGF-
I is not directly determining rates of protein synthesis
during feeding [37]; observations in line with our own
findings that infused amino acids improved protein bal-
ance across human muscles independently of plasma in-
sulin, IGF-I and IGF-I-binding proteins-1 and −3 [3].
A compensatory factor in the present study may be
that increased levels of growth hormone (GH) in liver-
IGF-I knockouts, observed in the present and a previous












Figure 4 Radioligand blot which demonstrates similar levels of
IGF binding proteins in skeletal muscle tissue among groups in
relationship to molecular weights (24–76 kD). Approximate
mobility of IGF-I binding proteins 1–6 is indicated to the left. The
same amount of proteins (±3%) was loaded in all tracks determined
by spectrophotometry.circulation [15] since cell experiments indicate that GH
phosphorylates similar or the same downstream targets
for protein synthesis as amino acids and IGF-I through
PI3-kinase dependent transduction [38]. Also, GH treat-
ment increased fractional muscle protein synthesis in
fed but not in starved pigs [39]. However, in a previous
study we used mice where circulating levels of both GH
and IGF-I were low and found that fractional muscle
protein synthesis increased normally to expected levels
after food intake [9]. Re-synthesis of muscle protein fol-
lowing starvation-refeeding did not relate to plasma GH
concentrations in either knockouts or wild type mice.
Therefore, we find it unlikely that GH explains rapid al-
terations in the feeding related muscle protein synthesis
evaluated in the present model.
We found no difference between liver IGF-I deficient
and wild type mice regarding translational control of
muscle protein synthesis. Both liver IGF-I knockouts and
wild type mice showed increased phosphorylation of
4EBP1 protein and decreased association of the 4E-BP1 ·
eIF4E complex. Also, p70s6 kinase phosphorylation was
increased similarly in both groups including upstream
phosphorylation of mTORser2448. Thus, effects by circulat-
ing IGF-I were less critical for the control of translation
initiation compared to other possible factors such as
plasma or extracellular amino acids, although consistent
changes in plasma amino acids were not observed among
IGF-I deficient and wild type mice at starvation-refeeding.
However, we did not measure eIF4G · eIF4E complexes,
which may be influenced by IGF-I as reported by others
using a hindlimb perfusion model, where physiologic con-
centrations of IGF-I (10 nM) in the presence of amino
acids were unable to dissociate 4E-BP1 from eIF4E, but in-
creased the assembly of eIF4G-4E complex and stimulated
protein synthesis [40].
Both liver IGF-I knockouts and wild type mice showed
increased muscle expression of the IGF-IR during starva-
tion, which usually reflects cellular processes related to
regeneration and hypertrophy of muscle cells [6]. This in-
creased receptor expression may reflect a positive feed-
back control of IGF-I signaling secondary to decreased
IGF-I protein close to membranes; a conclusion supported
by observations in cultured cells on increased IGF-IR
number and promoted amino acid transport related to
decreased extracellular concentration of amino acids, par-
ticularly glutamine [30,41]. Increased transcript and IGF-
IR protein levels have also been reported in response to
exercise [42-44], but information of similar changes in re-
lation to feeding are sparse, although equivalent observa-
tions have been reported [45,46]. Thus, IGF-IR expression
appears more tightly controlled than tissue IGF-I expres-
sion in skeletal muscle metabolism in response to starva-
tion – refeeding. By contrast to feeding, a recent report in
mice with non-functional IGF-IR showed that load-
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increased protein synthesis following exercise was not
entirely dependent on IGF-IR signaling.
There were no changes in either PI3K or AKT expres-
sion during starvation-refeeding, while mTOR transcript
expression was up-regulated in liver-IGF-I knockouts dur-
ing starvation, but without apparent change in protein
phosphorylation. This up-regulation in starved knockouts
may therefore reflect compensatory effects unrelated to
phosphorylation of mTOR, secondary to consistently de-
creased circulating IGF-I. If so, it remains to be explored
which factor(s) that up-regulates mTOR expression in
muscle tissue when endocrine IGF-I is declined, particu-
larly during starvation of knockout mice (Figure 2C).Conclusion
In conclusion, our present results confirm previous re-
ports that alteration in muscle protein synthesis during
starvation–refeeding relates to alteration in muscle mTOR
signaling, but not to Akt and PI3-kinase. Present findings
also support our previous conclusions that muscle pro-
duced IGF-I/IGF-IR are related to translation initiation of
muscle proteins at oral feeding. [5]. New information is
that endocrine IGF-I is not, critical for this effect. It re-
mains to determine to what extent local muscle IGF-I sig-
naling is critical, since systemically IGF-I (+/−) knockout
mice had normal fractional synthesis rate (%/hrs) in skel-
etal muscles at refeeding [9]. Whether a lack of effects by
liver derived IGF-I may be overcome by alternative signals
upstream to mTOR remains also to be determined, but in-
sulin and GH are probably not such candidates.
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